Life Sciences and Healthcare in China: Key Laws and Primary Sources
A maintained source spine for legal and compliance teams working across China product regulation, clinical research, health data, anti-corruption, procurement, intellectual property and cross-border regulatory interfaces.
Source guide
Use this page as a source spine, not as a substitute for full regulatory research.
Open the current official text, confirm its effective version and pair it with the specialist guide that operationalises the issue. English summaries on the portal are orientation only.
Six research collections organise the sector.
Each collection connects official authorities to the operational guide that owns the practical question.
Product registration, advertising and vigilance
NMPA registration, marketing-authorisation-holder duties, advertising, vigilance, product quality and recall.
Clinical research and human genetic resources
Clinical-trial management, GCP, ethics, subject protection, HGR and data-integrity rules.
Data, privacy and digital health
PIPL, Data Security Law, Cybersecurity Law and health-data transfer mechanisms.
Anti-corruption and procurement
Commercial bribery, criminal overlays, volume-based procurement and distribution practice.
IP, patent linkage and deals
Patent linkage, trade secrets, licensing, royalties, tax and foreign-exchange interfaces.
Foreign-regulator interfaces
FDA, EU MDR and IVDR, and investment-screening issues touching China assets or data.
Official authority station
Use current official materials; verify effective dates and implementing rules.
Pair sources with the guide that owns the issue.
Open the relevant operational route after locating the controlling materials.
Life Sciences Legal Hub
Open the broader sector issue map.
Open specialist route →02 · Research routeHuman Genetic Resources Compliance
Use for collection, storage, use and outbound provision questions.
Open specialist route →03 · Enforcement routeDawn Raid Response Playbook
Use for urgent anti-corruption inspection response.
Open specialist route →Escalate when a source must be applied to live facts.
A bibliography cannot resolve classification, licensing, data, enforcement or transaction questions on its own.
A deadline or authority action is liveA filing, inspection, recall, investigation or response date requires current advice.
Several regimes overlapProduct, clinical, data, HGR, employment or foreign-regulator rules interact.
An English summary is insufficientThe current official text, local implementation and facts must be reconciled.
Educational information only — not legal advice. Laws, procedures and regulatory practice can change; no lawyer-client relationship is created through use of this page.



